Andere Sprachen Aspira Women's Health Inc.

Aktien

A3EDH3

US04537Y2081

AWH

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 26.04.2024			% 5 Tage	% 1. Jan.
3,327 ^USD	+1,42 %		-4,68 %	-18,47 %

26.04.	Aspira Women's Health Inc. gibt bekannt, dass Minh Merchant als General Counsel, Chief Compliance Officer und Corporate Secretary mit Wirkung zum 6. Mai 2024 zurücktritt	CI
01.04.	ASPIRA WOMEN'S HEALTH INC. : Cantor Fitzgerald bekräftigt seine neutrale Bewertung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Aspira Women's Health Inc. Announces Minh Merchant Resigns as General Counsel, Chief Compliance Officer, and Corporate Secretary, Effective May 6, 2024	26.04.
Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California	09.04.
Aspira: Q4 Earnings Snapshot	28.03.
Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Posts Q4 Revenue $2.1M	28.03.
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results	28.03.
Aspira Women's Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Aspira Women's Health Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28.03.
Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call	25.03.
Aspira Women Health : Management Change/Compensation - Form 8-K	25.03.
Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference	21.03.
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President	18.03.
Aspira Women's Health Inc. Announces Executive Changes	18.03.
Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024	11.03.
Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference	22.02.
Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)	12.02.
Aspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the Philippines	06.02.
Aspira Women's Health Inc. Announces OvaSuite(SM) Distribution Agreement in the Philippines	06.02.
Aspira Women’s Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement	25.01.
Aspira Women's Health Inc. announced that it expects to receive $5.5 million in funding	24.01.
Aspira Women's Health Inc. Announces Resignation of Veronica G.H. Jordan from the Board of Directors	27.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aspira Women's Health Inc.

Aktien

A3EDH3

US04537Y2081

AWH

Andere Sprachen

Filter